| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Estrogen Receptor alpha | 11 | 2023 | 424 | 1.650 |
Why?
|
| Breast Neoplasms | 14 | 2025 | 2586 | 1.430 |
Why?
|
| Nuclear Receptor Coactivator 3 | 7 | 2020 | 253 | 0.800 |
Why?
|
| Endocrine Disruptors | 3 | 2020 | 55 | 0.570 |
Why?
|
| Breast | 2 | 2018 | 206 | 0.550 |
Why?
|
| Drug Resistance, Neoplasm | 5 | 2024 | 776 | 0.540 |
Why?
|
| Transcription, Genetic | 8 | 2020 | 1379 | 0.540 |
Why?
|
| E1A-Associated p300 Protein | 4 | 2020 | 49 | 0.510 |
Why?
|
| Proteomics | 3 | 2018 | 563 | 0.500 |
Why?
|
| Gene Expression Regulation, Neoplastic | 7 | 2021 | 1933 | 0.490 |
Why?
|
| MCF-7 Cells | 9 | 2020 | 207 | 0.470 |
Why?
|
| RNA, Long Noncoding | 2 | 2016 | 228 | 0.460 |
Why?
|
| Cyclin-Dependent Kinase 6 | 2 | 2025 | 48 | 0.440 |
Why?
|
| Cyclin-Dependent Kinase 4 | 2 | 2025 | 62 | 0.440 |
Why?
|
| Response Elements | 2 | 2015 | 99 | 0.420 |
Why?
|
| Transcriptional Activation | 5 | 2018 | 412 | 0.420 |
Why?
|
| DNA | 3 | 2020 | 1421 | 0.410 |
Why?
|
| Nucleosomes | 1 | 2013 | 32 | 0.410 |
Why?
|
| Estrogens | 5 | 2020 | 421 | 0.400 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2016 | 321 | 0.400 |
Why?
|
| DNA-Binding Proteins | 4 | 2017 | 1891 | 0.400 |
Why?
|
| Neurofibromin 1 | 2 | 2025 | 49 | 0.380 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2017 | 393 | 0.370 |
Why?
|
| HeLa Cells | 8 | 2017 | 684 | 0.350 |
Why?
|
| RNA, Untranslated | 1 | 2010 | 106 | 0.310 |
Why?
|
| Receptors, Estrogen | 4 | 2025 | 714 | 0.290 |
Why?
|
| Antineoplastic Agents, Hormonal | 2 | 2021 | 253 | 0.290 |
Why?
|
| Cell Line, Tumor | 8 | 2025 | 3502 | 0.280 |
Why?
|
| Signal Transduction | 6 | 2020 | 4484 | 0.280 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2004 | 588 | 0.280 |
Why?
|
| Receptors, Androgen | 2 | 2020 | 403 | 0.270 |
Why?
|
| Trans-Activators | 2 | 2013 | 676 | 0.250 |
Why?
|
| Promoter Regions, Genetic | 5 | 2018 | 1206 | 0.250 |
Why?
|
| Nuclear Proteins | 3 | 2017 | 1205 | 0.230 |
Why?
|
| Xenograft Model Antitumor Assays | 6 | 2025 | 948 | 0.220 |
Why?
|
| Genes, ras | 1 | 2004 | 99 | 0.220 |
Why?
|
| Transcription Factors | 4 | 2017 | 2344 | 0.210 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2025 | 576 | 0.210 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 186 | 0.210 |
Why?
|
| Protein Binding | 5 | 2020 | 1662 | 0.210 |
Why?
|
| Estrogen Antagonists | 2 | 2020 | 93 | 0.200 |
Why?
|
| Glucose | 2 | 2018 | 783 | 0.190 |
Why?
|
| Tamoxifen | 2 | 2020 | 345 | 0.190 |
Why?
|
| Humans | 30 | 2025 | 127095 | 0.180 |
Why?
|
| Unfolded Protein Response | 1 | 2020 | 61 | 0.170 |
Why?
|
| Animals | 16 | 2025 | 33154 | 0.170 |
Why?
|
| Apoptosis | 3 | 2024 | 1824 | 0.170 |
Why?
|
| Phosphorylation | 4 | 2018 | 1536 | 0.170 |
Why?
|
| Models, Biological | 3 | 2020 | 1360 | 0.160 |
Why?
|
| Organotin Compounds | 1 | 2020 | 6 | 0.160 |
Why?
|
| Stilbenes | 1 | 2020 | 37 | 0.160 |
Why?
|
| Hormones | 1 | 2020 | 156 | 0.160 |
Why?
|
| Trialkyltin Compounds | 1 | 2019 | 7 | 0.160 |
Why?
|
| Retinoid X Receptor alpha | 1 | 2019 | 16 | 0.160 |
Why?
|
| Biomarkers, Tumor | 3 | 2024 | 1561 | 0.160 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2021 | 219 | 0.160 |
Why?
|
| Histones | 3 | 2017 | 503 | 0.150 |
Why?
|
| Chromatin Immunoprecipitation | 3 | 2016 | 229 | 0.150 |
Why?
|
| Environmental Pollutants | 1 | 2020 | 73 | 0.150 |
Why?
|
| Multiprotein Complexes | 3 | 2017 | 191 | 0.150 |
Why?
|
| Cell Proliferation | 3 | 2025 | 2397 | 0.150 |
Why?
|
| Phosphofructokinase-2 | 1 | 2018 | 22 | 0.140 |
Why?
|
| Hepatocytes | 1 | 2019 | 231 | 0.140 |
Why?
|
| Epigenesis, Genetic | 3 | 2020 | 711 | 0.140 |
Why?
|
| Guanylate Cyclase | 1 | 2017 | 34 | 0.140 |
Why?
|
| Transcription Initiation, Genetic | 1 | 2017 | 7 | 0.140 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2017 | 348 | 0.140 |
Why?
|
| Transcription Elongation, Genetic | 1 | 2017 | 9 | 0.130 |
Why?
|
| Down-Regulation | 1 | 2019 | 649 | 0.130 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2017 | 43 | 0.130 |
Why?
|
| Histone Code | 1 | 2017 | 45 | 0.130 |
Why?
|
| Mutation | 5 | 2023 | 5947 | 0.130 |
Why?
|
| RNA Polymerase II | 1 | 2017 | 90 | 0.130 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2017 | 110 | 0.130 |
Why?
|
| Lysine | 1 | 2017 | 173 | 0.130 |
Why?
|
| Lipid Metabolism | 1 | 2019 | 350 | 0.130 |
Why?
|
| Translocation, Genetic | 1 | 2018 | 348 | 0.120 |
Why?
|
| Female | 15 | 2025 | 68483 | 0.120 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 2015 | 10 | 0.120 |
Why?
|
| Estrogens, Conjugated (USP) | 1 | 2015 | 16 | 0.120 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2016 | 74 | 0.120 |
Why?
|
| Methyltransferases | 1 | 2016 | 79 | 0.120 |
Why?
|
| Neoplasm Proteins | 2 | 2017 | 656 | 0.120 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2016 | 156 | 0.110 |
Why?
|
| Chromatin | 1 | 2018 | 472 | 0.110 |
Why?
|
| Luciferases | 3 | 2013 | 125 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2016 | 1231 | 0.110 |
Why?
|
| Databases, Factual | 1 | 2019 | 1194 | 0.110 |
Why?
|
| Mice | 9 | 2025 | 17679 | 0.110 |
Why?
|
| HEK293 Cells | 4 | 2020 | 770 | 0.110 |
Why?
|
| Binding Sites | 4 | 2018 | 1185 | 0.110 |
Why?
|
| Antineoplastic Agents | 1 | 2023 | 1758 | 0.100 |
Why?
|
| Models, Molecular | 3 | 2020 | 1058 | 0.100 |
Why?
|
| Recombinant Proteins | 3 | 2020 | 1282 | 0.100 |
Why?
|
| Sialoglycoproteins | 1 | 2013 | 42 | 0.100 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2013 | 17 | 0.100 |
Why?
|
| Peptide Fragments | 2 | 2017 | 756 | 0.100 |
Why?
|
| Pyridines | 2 | 2025 | 251 | 0.100 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2013 | 66 | 0.100 |
Why?
|
| RNA-Induced Silencing Complex | 1 | 2013 | 10 | 0.100 |
Why?
|
| Piperazines | 2 | 2025 | 256 | 0.100 |
Why?
|
| Gene Expression Regulation | 2 | 2013 | 2309 | 0.100 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2013 | 100 | 0.100 |
Why?
|
| Endometriosis | 1 | 2015 | 168 | 0.100 |
Why?
|
| Blotting, Western | 3 | 2016 | 1014 | 0.100 |
Why?
|
| RNA, Small Interfering | 2 | 2016 | 658 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase 6 | 1 | 2012 | 6 | 0.090 |
Why?
|
| Ribonuclease III | 1 | 2013 | 101 | 0.090 |
Why?
|
| Cryoelectron Microscopy | 3 | 2020 | 226 | 0.090 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2013 | 160 | 0.090 |
Why?
|
| Homeostasis | 1 | 2015 | 677 | 0.090 |
Why?
|
| Protein Interaction Domains and Motifs | 3 | 2017 | 133 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-ets | 2 | 2004 | 57 | 0.090 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 363 | 0.080 |
Why?
|
| RNA Interference | 3 | 2018 | 493 | 0.080 |
Why?
|
| Glucose Transporter Type 3 | 1 | 2010 | 6 | 0.080 |
Why?
|
| Iodide Peroxidase | 1 | 2010 | 8 | 0.080 |
Why?
|
| Transfection | 3 | 2017 | 948 | 0.080 |
Why?
|
| Histone Acetyltransferases | 2 | 2015 | 224 | 0.080 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2020 | 114 | 0.080 |
Why?
|
| Liver | 1 | 2017 | 1742 | 0.080 |
Why?
|
| Mice, Nude | 2 | 2021 | 708 | 0.080 |
Why?
|
| RNA-Binding Proteins | 1 | 2013 | 532 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 2 | 2015 | 720 | 0.070 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2012 | 316 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 2 | 2021 | 985 | 0.070 |
Why?
|
| Estradiol | 2 | 2020 | 477 | 0.070 |
Why?
|
| Prostatic Neoplasms | 1 | 2016 | 1395 | 0.070 |
Why?
|
| Cell Survival | 2 | 2020 | 840 | 0.070 |
Why?
|
| Carrier Proteins | 1 | 2013 | 1011 | 0.070 |
Why?
|
| Structure-Activity Relationship | 2 | 2020 | 565 | 0.070 |
Why?
|
| Acetylation | 2 | 2017 | 181 | 0.060 |
Why?
|
| Neoplasm Metastasis | 2 | 2020 | 689 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 1005 | 0.060 |
Why?
|
| Lung Neoplasms | 2 | 2018 | 1494 | 0.060 |
Why?
|
| Cell Nucleus | 2 | 2020 | 551 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2013 | 871 | 0.060 |
Why?
|
| Protein Conformation | 2 | 2020 | 801 | 0.060 |
Why?
|
| Obesity | 1 | 2017 | 2320 | 0.060 |
Why?
|
| Mice, SCID | 2 | 2020 | 570 | 0.060 |
Why?
|
| Cyclin D1 | 1 | 2025 | 108 | 0.060 |
Why?
|
| Silver Staining | 1 | 2004 | 5 | 0.060 |
Why?
|
| Proto-Oncogene Protein c-ets-2 | 1 | 2004 | 8 | 0.060 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 2004 | 9 | 0.060 |
Why?
|
| Baculoviridae | 1 | 2004 | 41 | 0.060 |
Why?
|
| Chromatography, Affinity | 1 | 2004 | 55 | 0.060 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2004 | 42 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2017 | 680 | 0.060 |
Why?
|
| Acetyltransferases | 1 | 2004 | 72 | 0.060 |
Why?
|
| CREB-Binding Protein | 1 | 2004 | 55 | 0.060 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2004 | 44 | 0.060 |
Why?
|
| Transcriptome | 2 | 2021 | 1066 | 0.050 |
Why?
|
| Genes, Reporter | 1 | 2004 | 346 | 0.050 |
Why?
|
| Cell Line | 2 | 2019 | 2564 | 0.050 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2024 | 220 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 1771 | 0.050 |
Why?
|
| Risk Factors | 1 | 2017 | 10610 | 0.050 |
Why?
|
| Rats | 2 | 2020 | 3392 | 0.050 |
Why?
|
| Neoplasms | 1 | 2016 | 2856 | 0.040 |
Why?
|
| Benzothiazoles | 1 | 2020 | 29 | 0.040 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2020 | 24 | 0.040 |
Why?
|
| Dihydrotestosterone | 1 | 2020 | 72 | 0.040 |
Why?
|
| Fluorescence | 1 | 2020 | 97 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2004 | 2543 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2004 | 676 | 0.040 |
Why?
|
| Thermodynamics | 1 | 2020 | 139 | 0.040 |
Why?
|
| Prognosis | 2 | 2021 | 4799 | 0.040 |
Why?
|
| Aromatase Inhibitors | 1 | 2020 | 78 | 0.040 |
Why?
|
| Endoribonucleases | 1 | 2020 | 84 | 0.040 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2020 | 38 | 0.040 |
Why?
|
| Toxicity Tests | 1 | 2020 | 34 | 0.040 |
Why?
|
| Nucleic Acid Conformation | 1 | 2020 | 169 | 0.040 |
Why?
|
| Co-Repressor Proteins | 1 | 2020 | 37 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2023 | 4446 | 0.040 |
Why?
|
| DNA, Neoplasm | 1 | 2020 | 283 | 0.040 |
Why?
|
| Deoxyglucose | 1 | 2019 | 42 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2020 | 187 | 0.040 |
Why?
|
| Knowledge Bases | 1 | 2019 | 38 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2019 | 90 | 0.040 |
Why?
|
| Protein Domains | 1 | 2020 | 239 | 0.040 |
Why?
|
| Gene-Environment Interaction | 1 | 2020 | 126 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2020 | 306 | 0.040 |
Why?
|
| Ligands | 1 | 2020 | 477 | 0.040 |
Why?
|
| ras Proteins | 1 | 2020 | 141 | 0.040 |
Why?
|
| Epigenomics | 1 | 2020 | 174 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 4509 | 0.040 |
Why?
|
| Mammals | 1 | 2019 | 247 | 0.040 |
Why?
|
| Adiposity | 1 | 2020 | 203 | 0.040 |
Why?
|
| Phosphoserine | 1 | 2018 | 36 | 0.040 |
Why?
|
| Transketolase | 1 | 2018 | 17 | 0.040 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2018 | 43 | 0.040 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2018 | 34 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2019 | 750 | 0.030 |
Why?
|
| Purines | 1 | 2018 | 110 | 0.030 |
Why?
|
| TATA Box | 1 | 1997 | 15 | 0.030 |
Why?
|
| TATA-Box Binding Protein | 1 | 1997 | 31 | 0.030 |
Why?
|
| Glycolysis | 1 | 2018 | 167 | 0.030 |
Why?
|
| Methylation | 1 | 2017 | 196 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1997 | 147 | 0.030 |
Why?
|
| Survival Rate | 1 | 2021 | 2111 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2018 | 270 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2019 | 1589 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2017 | 398 | 0.030 |
Why?
|
| Glucokinase | 1 | 2015 | 13 | 0.030 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2015 | 52 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 1997 | 511 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 330 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 1997 | 1484 | 0.030 |
Why?
|
| Environmental Exposure | 1 | 2016 | 260 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2020 | 1032 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 1127 | 0.030 |
Why?
|
| Cell Fractionation | 1 | 2013 | 23 | 0.030 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2013 | 60 | 0.020 |
Why?
|
| Base Sequence | 1 | 1997 | 2759 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2020 | 1728 | 0.020 |
Why?
|
| Drosophila | 1 | 2017 | 767 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 1598 | 0.020 |
Why?
|
| Endometrium | 1 | 2015 | 265 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 1997 | 3587 | 0.020 |
Why?
|
| Plasmids | 1 | 2013 | 445 | 0.020 |
Why?
|
| Matrix Metalloproteinases | 1 | 2012 | 60 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2013 | 784 | 0.020 |
Why?
|
| Drosophila Proteins | 1 | 2017 | 757 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2012 | 361 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 1997 | 2541 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 302 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2012 | 637 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 1350 | 0.020 |
Why?
|
| Cell Movement | 1 | 2012 | 851 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2015 | 3716 | 0.020 |
Why?
|
| Time Factors | 1 | 2017 | 6142 | 0.020 |
Why?
|
| Male | 2 | 2020 | 62658 | 0.010 |
Why?
|